Ember

AI denial prevention engine

San Francisco, California, United States

Claims/Revenue Cycle AI Revenue Cycle ManagementSeed

Ember is an AI-native healthcare denial prevention platform that helps healthcare providers reduce claim denials and administrative hours, while increasing net collection rates. The platform offers solutions for medical billing analysis, autonomous coding, and documentation time reduction.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Ember on @MedStartr Today Ember is an AI-native healthcare denial prevention platform that helps healthcare providers reduce claim denials and administrative hours, while increasing net collection rates. The platform offers solutions for medical billing analysis, autonomous coding, and documentation time reduction. #Musculoskeletal #Dermatology #Ophthalmology #Gastroenterology #ClaimsRevenueCycleAI #RevenueCycleManagement #MedMo #MedStartrVentures

https://www.medstartr.ai/s/h1V06IxCkIU

Get Involved in Ember

How We Help

Problem Statement

Healthcare providers struggle with claim denials, excessive administrative hours, and suboptimal net collection rates.

Core Technology

AI-native healthcare denial prevention platform

Key Differentiators

Offers 3-day turnaround for medical billing analysis; Enables sub-30-day pilot launches; Supports 26+ medical specialties; Integrates with Epic, Oracle Cerner, athenahealth, and eClinicalWorks EHR systems

Clinical Focus

Orthopedics; Dermatology; Ophthalmology; Gastroenterology

Company Info

Business Model: B2B SaaS
Founded: 2022
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.embercopilot.ai/

Disease Areas

Musculoskeletal Dermatology Ophthalmology Gastroenterology

Technologies

AI-native

Clinical & IP

🔬

Clinical Validation

98% coding accuracy, 57% denial reduction (real-world outcomes), 3-day implementation, HIPAA/SOC2/HITRUST certified

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Ember?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.